On the other hand, the proportion of detected mutations in BRCA1 and BRCA2 genes fell to 36% when we investigated the subgroup of families with at least two ovarian cancers and no breast cancer in their family history (Subgroup - only O) (Table 7). This evidence concerns the gene BRCA2 and breast carcinoma.